Andrew J Leidner

Andrew J Leidner

Centers for Disease Control and Prevention - Atlanta / United States
Economics & Econometrics / Economics
AD Scientific Index ID: 4469787
person_outline Andrew J Leidner's MOST POPULAR ARTICLES
1-) Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged≥ 65 years: updated recommendations of the Advisory …A Matanock, G Lee, R Gierke, M Kobayashi, A Leidner, T PilishviliMorbidity and Mortality Weekly Report 68 (46), 1069, 20192572019
2-) Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among US Adults: Updated Recommendations of the Advisory Committee on Immunization …M Kobayashi, JL Farrar, R Gierke, A Britton, L Childs, AJ Leidner, ...Morbidity and Mortality Weekly Report (MMWR) 71 (4), 109-117, 20221612022
3-) Association between social vulnerability and a county’s risk for becoming a COVID-19 hotspot—United States, June 1–July 25, 2020S Dasgupta, VB Bowen, A Leidner, K Fletcher, T Musial, C Rose, A Cha, ...Morbidity and Mortality Weekly Report 69 (42), 1535, 20201192020
4-) Use of recombinant zoster vaccine in immunocompromised adults aged≥ 19 years: recommendations of the Advisory Committee on Immunization Practices—United States, 2022TC Anderson, NB Masters, A Guo, L Shepersky, AJ Leidner, GM Lee, ...MMWR. Morbidity and Mortality Weekly Report 71, 20221902022
5-) Cost‐effectiveness of hepatitis C treatment for patients in early stages of liver diseaseAJ Leidner, HW Chesson, F Xu, JW Ward, PR Spradling, SD HolmbergHepatology 61 (6), 1860-1869, 20151532015